Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Jul;67(789):659–662. doi: 10.1136/pgmj.67.789.659

Cardioversion of atrial fibrillation of recent onset with flecainide.

B Carr 1, K Hawley 1, K S Channer 1
PMCID: PMC2399060  PMID: 1924053

Abstract

Twenty-eight patients with atrial fibrillation of less than 1 month's duration were given a single intravenous bolus of flecainide (2 mg/kg). Nineteen patients (68%) were successfully converted to sinus rhythm. Of the 19 patients with atrial fibrillation of less than 72 hours duration, 18 (95%) were successfully converted. Failure to cardiovert was associated with cardiomegaly on chest X-ray and larger left atrial diameter measured echocardiographically. Of the 9 patients who failed to convert, 2 had biochemical evidence of thyrotoxicosis and chronic obstructive pulmonary disease. Of the 19 patients successfully cardioverted, the atrial fibrillation complicated acute myocardial infarction in 3 cases and a pulmonary embolism in one. Six cases occurred post-operatively and in 3 out of 6 the patient was ventilated. No side effects were observed. The use of intravenous flecainide should avoid the need for electrical DC conversion even in sick patients. Failure of conversion is associated with covert underlying predisposing factors and duration of atrial fibrillation of more than 72 hours.

Full text

PDF
659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Channer K. S., Jones J. V. Atrial systole: its role in normal and diseased hearts. Clin Sci (Lond) 1988 Jul;75(1):1–4. doi: 10.1042/cs0750001. [DOI] [PubMed] [Google Scholar]
  2. Goy J. J., Kaufmann U., Kappenberger L., Sigwart U. Restoration of sinus rhythm with flecainide in patients with atrial fibrillation. Am J Cardiol. 1988 Aug 25;62(6):38D–40D. doi: 10.1016/0002-9149(88)90503-6. [DOI] [PubMed] [Google Scholar]
  3. Lipkin D. P., Frenneaux M., Stewart R., Joshi J., Lowe T., McKenna W. J. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J. 1988 May;59(5):572–577. doi: 10.1136/hrt.59.5.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Suttorp M. J., Kingma J. H., Lie-A-Huen L., Mast E. G. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol. 1989 Mar 15;63(11):693–696. doi: 10.1016/0002-9149(89)90253-1. [DOI] [PubMed] [Google Scholar]
  5. Wolf P. A., Kannel W. B., McGee D. L., Meeks S. L., Bharucha N. E., McNamara P. M. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke. 1983 Sep-Oct;14(5):664–667. doi: 10.1161/01.str.14.5.664. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES